Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus

Author:

Li Ning,Wang Li-Jun,Jiang Bo,Li Xiang-qian,Guo Chuan-long,Guo Shu-ju,Shi Da-Yong

Funder

National Natural Science Foundation of China

Shandong Provincial Natural Science Foundation for Distinguished Young Scholars

Key research and development project of Shandong province

Key Research Program of Frontier Sciences, CAS

Project of Discovery, Evaluation and Transformation of Active Natural Compounds

Strategic Biological Resources Service Network Program of Chinese Academy of Sciences

National Science Foundation of China (NSFC)-Shandong Joint Fund

National Program for Support of Top-notch Young Professionals

Taishan scholar Youth Project of Shandong province

Qingdao Marine Biomedical Science and Technology Innovation Center project

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference97 articles.

1. International Diabetes Federation. IDF Diabetes Atlas 8th Edition, http://www.diabetesatlas.org (Accessed November 14 2017).

2. Diabetes and cardiovascular risk factors: the Framingham study;Kannel;Circulation,1979

3. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus;Krolewski;Am. J. Cardiol.,1987

4. A review of the efficacy and safety of oral antidiabetic drugs;Stein;Expet Opin. Drug Saf.,2013

5. A perspective overview of clinically approved oral antidiabetic agents for the treatment of type 2 diabetes mellitus;He;Clin. Exp. Pharmacol. Physiol.,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3